Parker Hannifin Corp/ US7010941042 /
20/09/2024 21:59:57 | Var. -2.31 | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
623.96USD | -0.37% | 45,187 Fatturato: 28.2 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 80.21 bill.USD | 0.88% | 38.43 |
Newsfile Corp
04:15
NETA X First Batch Delivered in Hong Kong, Partnering with F1 in Schools Hong Kong, Co-Creating an I...
Newsfile Corp
03:18
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Befo...
Newsfile Corp
02:48
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Moderna, Inc. Investors to Secure Counsel Before Importan...
Newsfile Corp
02:11
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secur...
Newsfile Corp
01:30
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Import...